GlassScriptPhysician profile
Stanley S Kim
NPI 1003837840
$1,419.11
in general payments reported to CMS, 2019-2025
18 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $143 · 2021: $24.52 · 2022: $115 · 2023: $32.43 · 2024: $63.47 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $441.14 | 2019 | |
| Ivantis, INC | $184.09 | 2019 | |
| Medtronic USA, INC. | $142.23 | 2019 | |
| Allergan, INC. | $121.09 | 2019-2021 | |
| Oyster Point Pharma, INC. | $115.07 | 2022-2025 | Tyrvaya |
| Amgen INC. | $85.61 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $48.70 | 2025 | Tryptyr, Rocklatan |
| Sun Pharmaceutical Industries INC. | $42.02 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $41.18 | 2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $36.15 | 2019 | |
| Glaukos Corporation | $27.72 | 2022 | |
| Daiichi Sankyo INC. | $26.22 | 2025 | Enhertu |
| Glaxosmithkline, LLC. | $25.15 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $17.40 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abbvie INC. | $16.41 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.